STOCK TITAN

Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
Augmedix (AUGX) partners with Andor Health to enhance virtual care with ambient AI medical documentation, aiming to improve clinician-patient interactions and streamline workflows. The collaboration integrates AI-generated clinical notes within ThinkAndor® Virtual Visit, leveraging ambient documentation to transform care settings. Augmedix and Andor Health aim to optimize communication, reduce clinician burnout, and enhance patient outcomes through their innovative platforms.
Positive
  • None.
Negative
  • None.

Insights

The partnership between Augmedix and Andor Health represents a strategic move in the healthcare technology space, particularly in the realm of virtual care. By integrating ambient AI into the documentation process, the collaboration seeks to alleviate the administrative load on clinicians, potentially improving efficiency and accuracy in clinical note-taking. The use of Google Cloud MedLM further underscores the trend towards leveraging advanced machine learning models to enhance healthcare applications.

For stakeholders, the integration could mean a more streamlined workflow, which might translate into cost savings and improved patient care in the long term. However, the adoption curve and the integration's compatibility with existing systems may pose initial challenges. Moreover, the quality of AI-generated notes and their acceptance within the medical community will be critical to monitor.

The use of ambient AI in clinical settings is an emerging field that promises to redefine how patient data is captured and utilized. The collaboration between Augmedix and Andor Health is poised to push the envelope further by embedding AI-driven documentation directly into virtual visits. The potential benefits include reduced clinician burnout and faster treatment times due to more efficient data handling.

However, the success of such technology will heavily depend on its accuracy and the ability to seamlessly integrate with various electronic medical records (EMR) systems. Privacy and security concerns surrounding the handling of sensitive patient data by AI systems will also need to be rigorously addressed to maintain patient trust and comply with regulatory standards.

The announcement by Augmedix and Andor Health is indicative of the broader digital transformation within the healthcare industry. As virtual care becomes more prevalent, the demand for solutions that can support remote patient interactions efficiently is growing. The integration of AI-driven documentation tools directly into virtual care platforms could be a significant differentiator in the market.

From an investment perspective, this partnership could signal potential growth opportunities for companies like Augmedix and Andor Health. The ability to capture a larger market share in the virtual care domain could be reflected in their financial performance, making them attractive to investors looking for innovative companies in the healthcare technology sector.

SAN FRANCISCO and ORLANDO, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- In a significant move to streamline healthcare workflows and allow clinicians to focus on patient care, Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today that it has integrated with Andor Health, an AI-first cloud-based communication and collaboration platform for virtual care.

The alliance aims to harness the power of ambient documentation to transform the clinician-patient interaction landscape in mission-critical virtual care settings. As part of this collaboration, Andor and Augmedix will integrate physician clinical note creation directly within ThinkAndor® Virtual Visit capability for ambulatory with an AI-generated note available seconds after the virtual session.

Andor Health is changing the way care teams connect and collaborate with AI-instrumented and tailored workflows. At scale with health systems in the US, UK, and Canada, Andor Health’s AI-first platform, ThinkAndor®, delivers real-time actionable intelligence from electronic medical records, streamlining communication and collaboration workflows, accelerating treatment times, reducing clinician burnout, and fostering superior patient outcomes.

Augmedix, with its industry-leading platform, transforms natural conversations into organized medical notes, structured data, and point-of-care notifications. Renowned for liberating clinicians from administrative burdens, Augmedix uses ambient AI to create medical notes from clinician-patient conversations in various care settings, ultimately aiming to improve clinical, operational, and financial outcomes.

"This integration demonstrates Augmedix’s commitment to serve the broadest spectrum of specialties and care settings within the market," said Manny Krakaris, CEO of Augmedix. "The Andor-Augmedix approach is focused on unobtrusive integration wherein the ambient documentation is part of the native virtual workflow and end-user experience paradigm. Deep integration will also enable optimized upstream audio ingestion that generates the highest quality downstream note output quality scores.”  

“Andor Health, recently named the highest-rated Virtual Hospital Solution by BlackBook, is focused on helping health systems improve and accelerate clinical outcomes,” said Raj Toleti, CEO of Andor Health. “This integration with Augmedix will expand Andor’s flexibility to bring leading in-market capabilities that health systems already use into the virtual provider and patient experience. We believe health systems should have the option to leverage leading solutions for NLP-driven clinical note curation and to discreetly post those notes into the medical record without disruption for the clinical user via ThinkAndor®.”

As part of this collaboration, Augmedix and Andor will harness Google Cloud MedLM, launched in December of 2023. MedLM is a family of medically-tuned models for healthcare and life science industry use cases.

“This is an exciting time for digital health innovation, as the market flourishes with new GenAI solutions to meet the needs of providers in diverse care settings,” said Aashima Gupta, Global Director, Healthcare Strategy & Solutions, Google Cloud. “At Google Cloud, we are committed to forging an ecosystem of best-of-breed solutions through innovative partners such as Andor and Augmedix that leverage Google Cloud’s GenAI technology and share common commitment to provide an integrated experience for clinicians at the point of care.”

To learn more about Augmedix’s and Andor’s digital innovations, book time with Andor (sales@AndorHealth.com) or Augmedix (sales@augmedix.com) on April 9 through 11 at the Google Next conference in Las Vegas.

About Augmedix
Augmedix (Nasdaq: AUGX) empowers clinicians to connect with patients by liberating them from administrative burden through the power of ambient AI, data, and trust.

The platform transforms natural conversations into organized medical notes, structured data, and point-of-care notifications that enhance efficiency and clinical decision support.

Incorporating data from millions of interactions across all care settings, Augmedix collaborates with hospitals and health systems to improve clinical, operational, and financial outcomes.

Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit www.augmedix.com.

About Andor Health
Andor Health's mission is to change the way care teams connect and collaborate. Utilizing machine and human intelligence, their cloud-based platform transforms communication workflows and unlocks data from electronic medical records to provide actionable intelligence, improving clinician and patient experiences. Discover more at Andor Health.

Contact Information
Augmedix Investors:
Matt Chesler, CFA
FNK IR
augx@fnkir.com
investors@augmedix.com

Augmedix Media:
Kaila Grafeman
Augmedix
pr@augmedix.com

Andor Health Media Relations:
Jennifer Skitkso
Andor Health
Jennifer.Skitsko@andorhealth.com

Forward-Looking Statements
This press release contains “forward-looking statements” that involve a number of risks and uncertainties. Words such as “believes,” “may,” “will,” “estimates,” “potential,” “continues,” “anticipates,” “intends,” “expects,” “could,” “would,” “projects,” “plans,” “targets,” “excited,” “optimistic,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking statements include, without limitation, statements regarding the collaborations aim to harness the power of ambient physician documentation to transform the clinician-patient interaction landscape in mission-critical virtual care settings; the ability of the Augmedix platform to liberate clinicians from administrative burdens; Augmedix’s commitment to serve the broadest spectrum of specialties and care settings within the market; the focus of Andor and Augmedix on unobtrusive integration; deep integrations ability to enable optimized upstream audio ingestion that generates the highest quality downstream note output quality scores; the collaborations ability to bring leading in-market capabilities that health systems already use into the virtual provider and patient experience; revolutionizing ambient clinical documentation for ambulatory virtual care; the integration of physician clinical note creation directly within ThinkAndor® Virtual Visit capability for ambulatory with an AI-generated note available seconds after the virtual session; the harnessing of Google Cloud MedLM as part of the collaboration; and Google Cloud’s commitment to forging an ecosystem of best-of-breed solutions through innovative partners that leverage Google Cloud’s GenAI technology and share common commitment to provide an integrated experience for clinicians at the point of care. Actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in our most recent Form 10-K filed with the U.S. Securities and Exchange Commission on March 26, 2024, as well as other documents that may be filed by us from time to time with the U.S. Securities and Exchange Commission. The forward-looking statements included in this press release represent our views as of the date of this press release. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.


FAQ

What is the purpose of the partnership between Augmedix and Andor Health?

The partnership aims to streamline healthcare workflows, enhance clinician-patient interactions, and transform care settings through ambient AI medical documentation.

How will the collaboration benefit clinicians and patients?

Clinicians will have AI-generated clinical notes available seconds after virtual sessions, reducing administrative burdens and improving treatment times. Patients can expect superior outcomes and enhanced care experiences.

What platforms are involved in the integration?

Augmedix and Andor Health will integrate physician clinical note creation within ThinkAndor® Virtual Visit, leveraging AI-instrumented workflows and ambient documentation.

What technology will be used in the collaboration?

The collaboration will harness Google Cloud MedLM, a family of medically-tuned models for healthcare and life science industry use cases.

Augmedix, Inc.

NASDAQ:AUGX

AUGX Rankings

AUGX Latest News

AUGX Stock Data

116.16M
48.69M
1.5%
84.78%
2.16%
Health Information Services
Services-business Services, Nec
Link
United States of America
SAN FRANCISCO